Eman M.E. Dokla - Concepedia

Author

Eman M.E. Dokla

Ain Shams University ORCID

Also Known As

Eman Dokla, Eman M. Dokla, Eman M. E. Dokla, Eman M.E. Dokla, Eman Mahmoud Elawady Dokla

Publications

425

Citations

H-Index

Concepts

All Affiliations

Ain Shams University University of Sadat City University of Leeds University of Milan European Institute of Oncology

About

Eman M.E. Dokla is an author at Ain Shams University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	196
2	Natural Sciences	2	2	55
3	Biochemistry	1	1	11
4	Biomolecular Engineering	1	1	44
5	Cell Biology	1	1	11

Eman M.E. Dokla

Publications

220

Citations

H-Index

Page 1

	Year	Citations
Development of benzimidazole-based derivatives as antimicrobial agents and their synergistic effect with colistin against gram-negative bacteria Eman M.E. Dokla, Nader S. Abutaleb, Sandra N. Milik, European Journal of Medicinal Chemistry Synergistic EffectBenzimidazole-based DerivativesAntibioticsMedicineGram-negative Bacteria	2019	68
1,2,4-Oxadiazole derivatives targeting EGFR and c-Met degradation in TKI resistant NSCLC Eman M.E. Dokla, Chunsheng Fang, Khaled A. M. Abouzid, European Journal of Medicinal Chemistry Medicinal ChemistryC-met DegradationNatural SciencesMedicine1,2,4-Oxadiazole Derivatives	2019	44
SAR investigation and optimization of benzimidazole-based derivatives as antimicrobial agents against Gram-negative bacteria Eman M.E. Dokla, Nader S. Abutaleb, Sandra N. Milik, European Journal of Medicinal Chemistry Benzimidazole-based DerivativesAntibioticsMedicineGram-negative BacteriaAntibacterial Agent	2022	23
Discovery of a benzimidazole-based dual FLT3/TrKA inhibitor targeting acute myeloid leukemia Eman M.E. Dokla, Amal Kamal Abdel‐Aziz, Sandra N. Milik, Bioorganic & Medicinal Chemistry Hematological MalignancyOncologyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia	2021	20
Indolin-2-one derivatives as selective Aurora B kinase inhibitors targeting breast cancer Eman M.E. Dokla, Amal Kamal Abdel‐Aziz, Sandra N. Milik, Bioorganic Chemistry Medicinal ChemistryDrug TargetingMedicineReceptor Tyrosine KinaseIndolin-2-one Derivatives	2021	19
Targeting YAP Degradation by a Novel 1,2,4-Oxadiazole Derivative via Restoration of the Function of the Hippo Pathway Eman M.E. Dokla, Chunsheng Fang, Po‐Chen Chu, ACS Medicinal Chemistry Letters	2020	13
Identification of novel pyrazole and benzimidazole based derivatives as PBP2a inhibitors: Design, synthesis, and biological evaluation Menna-Allah W. Shalaby, Eman M.E. Dokla, Rabah Serya, Archives of Pharmaceutical Sciences Ain Shams University Novel PyrazolePharmacotherapyAntimicrobial ChemotherapyChemical BiologyAntibiotic Resistance	2019	11
Discovery of EMD37, a 1,2,4-oxadiazole derivative, as a novel endoplasmic reticulum stress inducer with potent anticancer activity Amal Kamal Abdel‐Aziz, Eman M.E. Dokla, Khaled A. M. Abouzid, Biochemical Pharmacology Medicine1,2,4-Oxadiazole DerivativePharmacologyCell DeathExtracellular Microvesicles	2022	11
Nanoemulgel formulation of a benzimidazole derivative for wound healing Eman M.E. Dokla, Riham I. El-Gogary, Mariam Gad, Journal of Drug Delivery Science and Technology	2023	11

Page 1